Results 161 to 170 of about 144,915 (188)
Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients. [PDF]
HemasphereGutiérrez-Herrero S, Martín-Martín L, Herrero-García M, Puertas B, da Silva Barbosa E, Mateos MV, López-Corral L, González-Calle V, Rey-Búa B, Martín-López AÁ, Pérez-López E, Sánchez-Guijo F, López-Parra M, Puig N, Orfao A, on behalf of the INCAR and Euroflow Consortium. +15 moreeuropepmc +1 more sourceGenotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort. [PDF]
AIDSBuzón-Martín L, Bernardino JI, Galindo Puerto MJ, Martín-Torres J, Alemán Valls MR, Torralba González de Suso M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello Úbeda A, Pedrero-Tomé R, Crusells Canales MJ, Calzado Isbert S, Aguilera García M, Hidalgo Tenorio C, Morano L, Vinuesa García D, de Andrés David C, Bernal Morell E, Martínez Álvarez RM, Cabello Clotet N, Tiraboschi J, Gimeno García A, Vivancos MJ, Troya J, the RELATIVITY Cohort Group
. +25 moreeuropepmc +1 more sourceOncology with common sense: beyond biologistic and pharmacological models. [PDF]
EcancermedicalscienceLastra R, Iranzo P, Benítez-Fuentes JD, Callejo A, Cruellas M, Gómez Ulla J, Pimentel I, Pérez-Gracia JL, Ramos M, Gil Moncayo F, Álvarez Alejandro M, Gascón M, Martínez Recio S, Rivero P, Bartolomé J, Lázaro Sánchez AD, Fernández Garay D, de Luna Aguilar A, Lorenzo Lorenzo I, Brunet J, Reguart N, Trapani D. +21 moreeuropepmc +1 more source
